Report on Plans and Priorities 2013-14

Analysis of Programs by Strategic Outcome

Program 1.6 - Biotechnology and Genomics

Description

Both knowledge and its application through innovative technology are vital for fostering advances in the sustainable development of aquatic resources. The Department is responsible for developing the knowledge necessary to inform the federal government's responsibility for regulation and the assessment of risk associated with fish products derived from biotechnology. Through the adoption of leading-edge genomics research and biotechnology tools and techniques, the Department also improves Fisheries and Oceans Canada's ability to protect endangered species, manage the opening and closing of fisheries, avoid overexploitation of resources, prosecute poachers, improve aquaculture practices, control disease outbreaks, and remediate contaminated sites.

Financial Resources ($ millions)

Total Budgetary
Expenditures
(Main Estimates)
2013-14
Planned Spending
2013-14
Planned Spending
2014-15
Planned Spending
2015-16
3.6 3.6 2.9 2.9

Human Resources (FTE)

2013-14 2014-15 2015-16
23 23 23

Performance Measurement

Expected
Result
Performance
Indicator
Target
Fisheries and Oceans Canada and Environment Canada decision-makers have access to biotechnology knowledge and advice for the regulation of fish products of biotechnology Percentage of responses to requests for biotechnology knowledge and advice completed and provided to decision-makers within the required timeline 100% by March 31, 2014
Fisheries and Oceans Canada decision-makers have access to genomics knowledge and advice for the management of fisheries and oceans Percentage of Genomics Research and Development Initiative projects that provided genomics knowledge and advice to decision-makers 100% within three
years following
completion of a
project by
March 31, 2014

Planning Highlights - Program-level

  • Genomics Research and Development Initiative Evaluation Management Action Plan - Complete implementation of the remaining recommendations of the Genomics Research and Development Initiative Evaluation's Management Action Plan.